Cancer is one of the leading causes of global mortality and imposes high costs on healthcare systems. In Brazil, a significant portion of resources is allocated to oncology, especially in the terminal phase. Palliative care has been associated with reduced hospital expenses and improved quality of life. This study aimed to compare direct medical costs in the last week of life of oncology patients receiving usual care (UC) or palliative care (PC).
Methods
A retrospective cohort study conducted at Santa Rita Hospital (Porto Alegre, RS), using data from 2021. Patients over 18 years old, hospitalized for ≥7 days, whose death resulted from cancer progression, were included. The sample comprised 58 individuals: 41 in PC and 17 in UC. Direct medical costs included medications, procedures, laboratory and imaging exams, adjusted for inflation and converted to US dollars.
Results
Despite no statistically significant difference in the median of total cost (P = 0.4493), the median cost was lower in the PC group (USD 67.5) compared to the UC group (USD 91.5). Patients receiving palliative care had reduced costs related to procedures, laboratory tests, and imaging exams.
Conclusion
The integration of palliative care was associated with reduced specific expenses and greater multidisciplinary support, indicating potential for resource optimization in oncology. These results reinforce the importance of systematic incorporation of this approach in the Brazilian context.
BrayFLaversanneMWeiderpassESoerjomataramI. The ever‐increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029-3030. doi:10.1002/cncr.33587
2.
WqspP. National cancer institute and the 2023 -2025 estimate – Cancer incidence in Brazil. Rev Bras Ginecol E Obstetrícia RBGO Gynecol Obstet. 2023;45(01):001-002. doi:10.1055/s-0043-1762925
3.
BigoniAFerreira AntunesJLWeiderpassEKjærheimK. Describing mortality trends for major cancer sites in 133 intermediate regions of Brazil and an ecological study of its causes. BMC Cancer. 2019;19(1):940. doi:10.1186/s12885-019-6184-1
4.
ChenSCaoZPrettnerK, et al.Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465-472. doi:10.1001/jamaoncol.2022.7826
5.
LanaAPPerelmanJGurgel AndradeEIAcúrcioFGuerraAACherchigliaML. Cost analysis of cancer in Brazil: a population-based study of patients treated by public health system from 2001-2015. Value Health Reg Issues. 2020;23:137-147. doi:10.1016/j.vhri.2020.05.008
6.
YadavSHellerIWSchaeferN, et al.The health care cost of palliative care for cancer patients: a systematic review. Support Care Cancer. 2020;28(10):4561-4573. doi:10.1007/s00520-020-05512-y
7.
CheungMCEarleCCRangrejJ, et al.Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer. 2015;121(18):3307-3315. doi:10.1002/cncr.29485
8.
KavalieratosDCorbelliJZhangD, et al.Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104-2114. doi:10.1001/jama.2016.16840
9.
HaroenHMaulanaSHarunH, et al.The benefits of early palliative care on psychological well-being, functional status, and health-related quality of life among cancer patients and their caregivers: a systematic review and meta-analysis. BMC Palliat Care. 2025;24(1):120. doi:10.1186/s12904-025-01737-y
10.
SeowHBarberaLCMcGrailK, et al.Effect of early palliative care on end-of-life health care costs: a population-based, propensity score–matched cohort study. JCO Oncol Pract. 2022;18(1):e183-e192. doi:10.1200/OP.21.00299
11.
TriplettDPLeBrettWGBryantAK, et al.Effect of palliative care on aggressiveness of end-of-life care among patients with advanced cancer. J Oncol Pract. 2017;13(9):e760-e769. doi:10.1200/JOP.2017.020883
12.
AgarwalAKarikiosDJStocklerMRMortonRL. Discussion of costs and financial burden in clinical practice: a survey of medical oncologists in Australia. PLoS One. 2022;17(10):e0273620. doi:10.1371/journal.pone.0273620
13.
HusereauDDrummondMAugustovskiF, et al.Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMC Med. 2022;20(1):23. doi:10.1186/s12916-021-02204-0
14.
MayPNormandCCasselJB, et al.Economics of palliative care for hospitalized adults with serious illness: a meta-analysis. JAMA Intern Med. 2018;178(6):820-829. doi:10.1001/jamainternmed.2018.0750
15.
MayPNormandCMorrisonRS. Economic impact of hospital inpatient palliative care consultation: review of current evidence and directions for future research. J Palliat Med. 2014;17(9):1054-1063. doi:10.1089/jpm.2013.0594
16.
ItoSSCMotkeBBLinharesAB, et al.Evaluation of direct medical costs and associated factors within the last 30 days of life of hospitalized cancer patients. Am J Hosp Palliat Med. 2023;40(10):1098-1105. doi:10.1177/10499091221147906
17.
DeebSChinoFLDiamondLC, et al.Disparities in care management during terminal hospitalization among adults with metastatic cancer from 2010 to 2017. JAMA Netw Open. 2021;4(9):e2125328. doi:10.1001/jamanetworkopen.2021.25328
18.
JansenKHaugenDFPontLRuthsS. Safety and effectiveness of palliative drug treatment in the last days of life—A systematic literature review. J Pain Symptom Manag. 2018;55(2):508-521. doi:10.1016/j.jpainsymman.2017.06.010
19.
KehlKAKowalkowskiJA. A systematic review of the prevalence of signs of impending death and symptoms in the last 2 weeks of life. Am J Hosp Palliat Med. 2013;30(6):601-616. doi:10.1177/1049909112468222
20.
BrueraEYennurajalingamS. Palliative care in advanced cancer patients: how and when?Oncologist. 2012;17(2):267-273. doi:10.1634/theoncologist.2011-0219
21.
BreuerBFleishmanSBCrucianiRAPortenoyRK. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29(36):4769-4775. doi:10.1200/JCO.2011.35.0561
22.
SampaioSGDSMMottaLBDCaldasCP. Medicamentos e Controle de dor: Experiência de um Centro de Referência em Cuidados Paliativos no Brasil. Rev Bras Cancerol. 2019;65:2. doi:10.32635/2176-9745.RBC.2019v65n2.365
23.
LundorffLPeuckmannVSjøgrenP. Pain management of opioid‐treated cancer patients in hospital settings in Denmark. Acta Anaesthesiol Scand. 2008;52(1):137-142. doi:10.1111/j.1399-6576.2007.01522.x
24.
SolanoJPGomesBHigginsonIJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag. 2006;31(1):58-69. doi:10.1016/j.jpainsymman.2005.06.007
HoJFVYaakupHLowGSHWongSLThoLMTanSB. Morphine use for cancer pain: a strong analgesic used only at the end of life? A qualitative study on attitudes and perceptions of morphine in patients with advanced cancer and their caregivers. Palliat Med. 2020;34(5):619-629. doi:10.1177/0269216320904905
27.
MarraARPuig-AsensioMBalkenendeELivorsiDJGotoMPerencevichEN. Antibiotic use during end-of-life care: a systematic literature review and meta-analysis. Infect Control Hosp Epidemiol. 2021;42(5):523-529. doi:10.1017/ice.2020.1241
28.
ChibaMNegishiMMiyagawaS, et al.Status and cost analysis of antimicrobial treatment of terminally ill patients with hematological malignancy in an acute hospital. J Infect Chemother. 2020;26(12):1288-1293. doi:10.1016/j.jiac.2020.07.017
29.
KimJHYooSHKeamBHeoDS. The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study. J Antimicrob Chemother. 2023;78(1):302-308. doi:10.1093/jac/dkac405
30.
KimJHYooSHKeamBHeoDS. Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation. J Antimicrob Chemother. 2023;78(7):1694-1700. doi:10.1093/jac/dkad156
31.
LarnardJSteadWBranch-EllimanW. Considering patient, family, and provider goals and expectations in a rapidly changing clinical context: a framework for antimicrobial stewardship at the end of life. Infect Dis Clin. 2023;37(1):139-151. doi:10.1016/j.idc.2022.09.003
32.
VanbutseleGVan BelleSSurmontV, et al.The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life: a randomised controlled trial. Eur J Cancer. 2020;124:186-193. doi:10.1016/j.ejca.2019.11.009
33.
ChungVSunVRuelNSmithTJFerrellBR. Improving palliative care and quality of life in pancreatic cancer patients. J Palliat Med. 2022;25(5):720-727. doi:10.1089/jpm.2021.0187
34.
Van BeekFEWijnhovenLMAHoltmaatK, et al.Psychological problems among cancer patients in relation to healthcare and societal costs: a systematic review. Psychooncology. 2021;30(11):1801-1835. doi:10.1002/pon.5753
35.
MossmanBPerryLMWalshLE, et al.Anxiety, depression, and end‐of‐life care utilization in adults with metastatic cancer. Psychooncology. 2021;30(11):1876-1883. doi:10.1002/pon.5754
36.
IannizziPFeltrinAMartinoR, et al.Psychological assessment and the role of the psychologist in early palliative care. Front Psychol. 2024;15:1437191. doi:10.3389/fpsyg.2024.1437191
37.
DerryHMReidMCPrigersonHG. Advanced cancer patients’ understanding of prognostic information: applying insights from psychological research. Cancer Med. 2019;8(9):4081-4088. doi:10.1002/cam4.2331
38.
KimKWooJ. Characteristics and effectiveness of individual psychotherapy for palliative and end-of-life care: a literature review for randomized controlled trials. Psychiatry Investig. 2024;21(5):433-448. doi:10.30773/pi.2023.0357
